N※N

Ozempic/Wegovy Popularity Fading Among Older Americans

  //health-fitness.news-articles.net/content/2026/ .. ovy-popularity-fading-among-older-americans.html
  Published in Health and Fitness on Sunday, February 15th 2026 at 23:22 GMT by The Baltimore Sun
      Locales: Maryland, Pennsylvania, UNITED STATES

BALTIMORE - The initial wave of excitement surrounding weight-loss drugs like Ozempic and Wegovy is showing signs of receding, particularly among older Americans. While initially lauded as a groundbreaking advancement in the fight against obesity, a growing number of seniors are discontinuing treatment, revealing a complex interplay of financial, physiological, and lifestyle factors.

These medications, originally developed to manage type 2 diabetes, gained significant off-label popularity for weight loss, offering substantial results for many. However, recent data and anecdotal evidence suggest a considerable number of older adults are opting to stop, prompting a reevaluation of the drugs' role in long-term health strategies for this demographic.

Dr. Eleanor Vance, a geriatrician at Johns Hopkins Bayview Medical Center, notes a clear increase in patients expressing a desire to discontinue the drugs. "We initially saw a surge in interest, and many patients experienced positive weight loss outcomes," Dr. Vance explains. "However, the long-term viability of remaining on these medications is proving problematic for a significant portion of our senior population. The financial strain is a major driver, but it's not the only factor."

The financial burden is undeniably substantial. Ozempic and Wegovy are expensive medications, and while some insurance plans offer coverage, it is often inconsistent and subject to high co-pays or prior authorization requirements. For seniors living on fixed incomes, the ongoing cost can be prohibitive, forcing a difficult choice between medication and other essential expenses like food or healthcare. The potential for out-of-pocket expenses exceeding several hundred dollars per month is a reality for many, making the drugs unsustainable for long-term use.

Beyond the financial implications, the side effect profile of these medications is also contributing to the decline in usage. Common side effects, such as nausea, fatigue, and gastrointestinal distress, are often manageable for younger, healthier individuals. However, these effects can be significantly more debilitating for older adults, who may already be managing pre-existing health conditions.

Margaret Olsen, 78, of Towson, Maryland, shared her experience. "I did lose some weight initially, which was encouraging," she says. "But the constant nausea and weakness were unbearable. It made everyday activities difficult, and frankly, I felt sicker on the medication than I did before." Such accounts are becoming increasingly common, highlighting the need for careful consideration of individual patient health profiles before prescribing these drugs.

The growing realization that these medications are not a "magic bullet" is also playing a crucial role in the trend. Without concurrent and sustained lifestyle modifications, weight regain is almost inevitable upon discontinuation of the drugs. This realization has spurred a shift in focus toward more holistic and sustainable approaches to weight management.

Sarah Chen, a registered dietitian specializing in geriatric nutrition, emphasizes the importance of long-term lifestyle changes. "These medications can be a helpful adjunct to a comprehensive weight management plan, but they are not a substitute for a healthy diet, regular exercise, and behavior modification," Chen states. "We are now focusing on empowering our patients to adopt lasting habits that will support their health and well-being, not just achieving a temporary weight loss." Chen's approach aligns with a growing body of evidence emphasizing the benefits of preventative care and lifestyle interventions in managing chronic conditions.

Doctors are now adopting a more cautious approach, thoroughly discussing the potential risks and benefits of these medications with patients and emphasizing the need for meticulous monitoring and a firm commitment to lifestyle changes. The current trend serves as a critical reminder that weight loss is not a one-size-fits-all endeavor, and a personalized, holistic approach is paramount, especially for older adults.

The situation also underscores the broader need for affordable and accessible healthcare options that prioritize preventative care and long-term wellness. While medications like Ozempic and Wegovy can play a role in combating obesity, their effectiveness is inextricably linked to a commitment to sustainable lifestyle changes and equitable access to comprehensive healthcare support.